Methyl 1-methyl-9H-pyrido[3,4-b]indole-3-carboxylate, 97%, 5g

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 25g

3-N-Boc-Aminocyclohexanone, 97.0%, 100g

4-Fluoro-2-nitrophenol, 99.0%, 10g

4-Ethylpiperidine hydrochloride, 98.0%, 1g

2-HYDROXY-2-PHOSPHONO-3-(PYRIDIN-3-YL)PROPANOIC ACID, 95%, 100mg

(R)-(+)-2-Bromopropionic acid, 98.0%, 5g

Thalidomide-O-C7-acid, 100mg

Bis(2,4,6-trichlorophenyl) Oxalate [Chemiluminescence reagent for the determination of fluorescent compounds]>98.0%(T)1g

4-Amino-2-fluoro-5-nitrobenzonitrile, 95.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 97%, 25g

5'-Bromo-2'-hydroxypropiophenone, 95.0%, 25g

2-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)isoindoline-1,3-dione, 95.0%, 500g